TNFRSF9 and systemic lupus erythematosus: On the other hand, agonistic anti-CD137 mAb treatment of NZB/NZW.F1 mice suppresses GC formation and anti-dsDNA IgG production without inducing immunosuppression, reversing SLE and prolonging the mouse’s lifespan [70].